A valid U.S. passport is required to enter and depart Ecuador. Tourists must also provide evidence of return or onward travel. U.S. citizens traveling on regular passports do not need a visa for a stay of 90 days or less. Those planning a longer visit must obtain a visa in advance of arrival. Travelers who stay in Ecuador beyond the allowed entry time are charged a substantial fee and are barred from re-entering Ecuador for six months from the date of departure. An airport exit tax is required when departing Ecuador.
Embassy
and Consulate in the US
:
For further information regarding entry, exit, and customs requirements, travelers should contact the Ecuadorian Embassy at 2535 15th Street, NW, Washington, DC 20009 ((202-234-7166) or nearest Consulate General: CA (323-658-6020
or 415-957-5921 or 22), FL (305-539-8214 or 15), IL (312-329-0266),
LA (504-523-3229), MA (617-738-9465 or 68), NJ (201-985-2959 or 60),
NY (212-808-0211 or 12), or TX (713-572-8731).
Ecuador
Travel
Health Information :
Vaccination or Disease
Recommendations or Requirements for Vaccine-Preventable Diseases
Recommended if you are not up-to-date with routine shots such as, measles/mumps/rubella (MMR) vaccine, diphtheria/pertussis/tetanus (DPT) vaccine, etc.
CDC yellow fever vaccination recommendation for travelers to Ecuador: For all travelers >9 months of age who are traveling to areas east of the Andes Mountains (see Map 4-16 ), NOT including the cities of Quito and Guayaquil or the Galápagos Islands. Ecuador requires travelers arriving from countries where yellow fever is present to present proof of yellow fever vaccination. Vaccination should be given 10 days before travel and at 10 year intervals if there is on-going risk. Find an authorized U.S. yellow fever vaccination clinic .
Recommended for all unvaccinated people traveling to or working in countries with an intermediate or high level of hepatitis A virus infection ( see map ) where exposure might occur through food or water. Cases of travel-related hepatitis A can also occur in travelers to developing countries with "standard" tourist itineraries, accommodations, and food consumption behaviors.
Recommended for all unvaccinated persons traveling to or working in countries with intermediate to high levels of endemic HBV transmission ( see map ) and who might be exposed to blood or body fluids, have sexual contact with the local population, or be exposed through medical treatment, such as for an accident, and for all adults requesting protection from HBV infection.
Recommended for all unvaccinated people traveling to or working in Tropical South America, especially if visiting smaller cities, villages, or rural areas and staying with friends or relatives where exposure might occur through food or water.
Recommended for travelers spending a lot of time outdoors, especially in rural areas, involved in activities such as bicycling, camping, hiking, or work. Also, children are considered at higher risk because they tend to play with animals and may not report bites.
Malaria
Drugs to Prevent Malaria (antimalarial drugs)
If you will be visiting a malaria risk area in Ecuador, you will need to take one of the following antimalarial drugs: atovaquone/proguanil , doxycycline , or mefloquine ( primaquine in special circumstances and only after G6PD testing).
Note: Chloroquine is NOT an effective antimalarial drug in Ecuador and should not be taken to prevent malaria in this region.
Malaria risk area in Ecuador: Risk in all areas at altitudes below 1,500 m (<4,921 ft). No risk in the cities of Guayaquil and Quito, the central highland tourist areas, and the Galápagos Islands.
